sales@scalarmarketresearch.com |  +1-800-213-5170  (U.S./ Canada Toll-free) |  REGISTER |  SIGN IN

Home >> Reports >> specialty generics market

report

Specialty Generics Market, By Type (Injectables, Oral, Others), Application (Oncology, Inflammatory Conditions, Multiple Sclerosis, Hepatitis C, Others), End-use (Specialty Pharmacy, Retail Pharmacy, Hospital Pharmacy) – Global Revenue, Trends, Growth, Share, Size, and Forecast to 2022

HC417 October 2017 100+ FREE 10% CUSTOMIZATION

Specialty generic drugs are specific injectable drugs that are derived from living cells. They are used to treat complex diseases such as cancer, arthritis, hemophilia, and many more. The healthcare cost is increasing because of expensive pharmaceuticals; hence, governments in various countries are increasing funding to ensure fulfillment of healthcare expenditure. According to the latest research study conducted, the number of cancer cases have increased by many folds in the year 2017. This is increasing the need for developing novel, enhanced, and cost-effective methods to produce specialized generic medicines. This report studies the current and future aspects of the specialty generics market.

The report on the global specialty generics market uses the top-down and bottom-up approaches to define, analyze, and describe the market trends for the next five years. The report also tracks the emerging applications, innovative technologies, and mergers & acquisitions. It also focuses on the growth drivers and restraints for the key market players during the forecast period.

KEY BENEFITS OF THE REPORT

  • In-depth analysis of the market ecosystem and its impact on the revenue growth
  • Understanding of the strategies that are being adopted by the key players in this market to stay competitive
  • Valuable insights into the key technological and market trends impacting this market

KEY PREMIUM INDUSTRY INSIGHTS

  • The specialty generics market is growing at a rapid pace during the forecasted period mainly because of rising occurrences of chronic diseases such as cancer, multiple sclerosis, hepatitis C, and so on. Several drugs are facing the challenge of patent expiration which is giving rise to growth of generic medicines.
  • This is impacting the pharmaceutical industry wherein the key market players are now collaborating to create newer growth opportunities for the specialty generics market. In addition, factors like financial and economic situation and increasing aging population is promoting the market growth.

The global specialty generics market is divided into four major geographical segments which are North America, Europe, Asia-Pacific, and Rest of the World (RoW). The North America region holds the highest market share of the specialty generics market and proves to be the largest revenue contributor. The region continues to dominate the global market during the forecasted period because of presence of well-developed healthcare facilities. The specialty generics market is also growing at a steady pace in the Europe region because of high demand for advanced therapeutics for some chronic diseases. The strong distribution network among the key players is also driving the market in this region. The Asia Pacific market is also expected to grow at a fast pace, because of increasing occurrences of chronic diseases among the population, and high demand for cost-effective generic drugs. Government in developing countries like India and China are making increasing investments to upgrade the available healthcare facilities which are favoring the progress of the specialty generics market in this region.

RESEARCH METHODOLOGY

The research methodology for Scalar Market Research’s specialty generics market report utilizes a combination of top-down and bottom-up research formats. Our primary focus on continuous market tracking, rigorous fact-checking, data-triangulation, and multiple layers of quality control ensures high-quality data that can be leveraged for actionable research insights.

To know about the assumptions considered for the study, Download PDF Sample.

MARKET SEGMENTATION

This report analyzes the specialty generics market by the following segments:

  • Specialty Generics Market, by Type
    • Injectables
    • Oral
    • Others
  • Specialty Generics Market, by Application
    • Oncology
    • Inflammatory Conditions
    • Multiple Sclerosis
    • Hepatitis C
    • Others
  • Specialty Generics Market, by End-use
    • Specialty Pharmacy
    • Retail Pharmacy
    • Hospital Pharmacy

 KEY MARKET PLAYERS

Key players in the specialty generics market include:

  • Teva Pharmaceuticals USA, Inc.
  • Mylan N.V.
  • Sandoz International GmbH
  • Akorn, Inc.
  • Mallinckrodt
  • Valeant Pharmaceuticals International, Inc.
  • Pfizer Inc.
  • Endo Pharmaceuticals Inc.
  • Apotex Corp.
  • Sun Pharmaceutical Industries Ltd.

GEOGRAPHIC COVERAGE AND ANALYSIS

This granular market research report covers the following geographic regions in great detail:

  • NORTH AMERICA
    • U.S.
    • Rest of North America
  • EUROPE
    • France
    • Germany
    • U.K
    • Rest of Europe
  • ASIA-PACIFIC
    • China
    • India
    • Japan
    • Rest of Asia-Pacific
  • REST OF THE WORLD
    • Latin America
    • Middle East & Africa

TRENDING RELATED REPORT

Respiratory Disease Market, by Diseases (Pulmonary Hypertension, Cystic Fibrosis, Asthma, And Chronic Obstructive Pulmonary Disease) - Global Revenue, Trends, Growth, Share, Size and Forecast to 2022


  1. MARKET OVERVIEW
    1. Market Definitions
    2. Research Methodology
    3. Market Segmentation
  2. EXECUTIVE SUMMARY
  3. MARKET DYNAMICS
    1. Drivers
    2. Restraints
    3. Opportunities
    4. Premium Industry Trends
  4. INDUSTRY ANALYSIS
    1. Value Chain Analysis
  5. SPECIALTY GENERICS MARKET, BY TYPE
    1. Segment Share
    2. By Type
      1. Injectables
      2. Oral
      3. Others
  6. SPECIALTY GENERICS MARKET, BY APPLICATION
    1. Segment Share
    2. By Application
      1. Oncology
      2. Inflammatory Conditions
      3. Multiple Sclerosis
      4. Hepatitis C
      5. Others
  7. SPECIALTY GENERICS MARKET, BY END-USE
    1. Segment Share
    2. By End-use
      1. Specialty Pharmacy
      2. Retail Pharmacy
      3. Hospital Pharmacy
  8. SPECIALTY GENERICS MARKET, BY GEOGRAPHY
    1. Segment Share
    2. North America
      1. By Regions
        1. U.S.
        2. Rest of North America
      2. By Type
      3. By Application
      4. By End-use
    3. Europe
      1. By Regions
        1. France
        2. Germany
        3. U.K.
        4. Rest of Europe
      2. By Type
      3. By Application
      4. By End-use
    4. Asia-Pacific
      1. By Regions
        1. China
        2. India
        3. Japan
        4. Rest of Asia-Pacific
      2. By Type
      3. By Application
      4. By End-use
    5. Rest of the World
      1. By Regions
        1. Latin America
        2. Middle East & Africa
      2. By Type
      3. By Application
      4. By End-use
  9. COMPETITIVE LANDSCAPE
    1. Market Positioning of Key Players, 2016
  10. KEY MARKET PLAYERS
    1. Teva Pharmaceuticals USA, Inc.
      1. Overview
      2. Key Strategies
      3. Key Developments
    2. Mylan N.V.
      1. Overview
      2. Key Strategies
      3. Key Developments
    3. Sandoz International GmbH
      1. Overview
      2. Key Strategies
      3. Key Developments
    4. Akorn, Inc.
      1. Overview
      2. Key Strategies
      3. Key Developments
    5. Mallinckrodt
      1. Overview
      2. Key Strategies
      3. Key Developments
    6. Valeant Pharmaceuticals International, Inc.
      1. Overview
      2. Key Strategies
      3. Key Developments
    7. Pfizer Inc.
      1. Overview
      2. Key Strategies
      3. Key Developments
    8. Endo Pharmaceuticals Inc.
      1. Overview
      2. Key Strategies
      3. Key Developments
    9. Apotex Corp.
      1. Overview
      2. Key Strategies
      3. Key Developments
    10. Sun Pharmaceutical Industries Ltd.
      1. Overview
      2. Key Strategies
      3. Key Developments
  11. SCALAR 360 DEGREE MARKET PERSPECTIVE
  12. APPENDIX
Please submit your enquiry below so our representative can get in touch with you
*
*
*
*
*
*

USA - CANADA TOLL FREE
+1-800-213-5170

EMAIL
sales@scalarmarketresearch.com

Benefits of Buying From Scalar

Unparalleled Expertise

Our industry experts hold inimitable know-how across wide range of industry verticals

Assured Quality

We deliver high-quality, real-time and data-driven industry insights to our clients

24x7 Analyst Support

We offer pre-purchase and post-purchase support from our industry experts

Privacy & Security

All your personal information and confidential details are safe and secure with us